Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abnormal tissue destruction via thermal injury" refers to the damage caused to tissues following exposure to excessive temperatures, leading to denaturation of proteins, cell membrane disruption, interruption of cellular homeostasis, thrombosis of local vasculature, and various forms of cell death including necrosis and apoptosis[2][3][5]. This process is not a discrete molecular target, receptor, or protein, but rather a description of a clinical and pathological phenomenon that can affect various tissues in the body, most frequently the skin in the case of burns. The mechanisms involved include protein denaturation, membrane disruption, mitochondrial dysfunction, oxidative stress, calcium influx, and activation of regulated cell death pathways[2][3][4]. "Abnormal tissue destruction via thermal injury" should not be considered a molecular target such as a receptor, enzyme, or transporter. There is no single molecule with this name; therefore, this is not a suitable entry for a molecular target database.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Abnormal tissue destruction via thermal injury.